comparemela.com
Home
Live Updates
Meeting Of The Gastrointestinal Drugs Advisory Committee - Breaking News
Pages:
Latest Breaking News On - Meeting of the gastrointestinal drugs advisory committee - Page 1 : comparemela.com
FDA Committee Votes Against Risk-Benefit Profile of OCA 25 mg for NASH
The June 22, 2023 PDUFA date for obeticholic acid 25 mg oral tablets for the treatment of precirrhotic liver fibrosis appears to be in jeopardy after a May 23, 2023 meeting of the FDA's Gastrointestinal Drugs Advisory Committee.
Jerry durso
Intercept pharmaceuticals
Meeting of the gastrointestinal drugs advisory committee
Drug administration
Intercept pharmaceuticals inc
Gastrointestinal drugs advisory committee
Advisory committee
New drug application
Action date
Chief executive officer
vimarsana © 2020. All Rights Reserved.